TrialThorax2025

Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial.

Lennie Derde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.